about
Follicular lymphoma: 2012 update on diagnosis and managementTargeted Therapies for the Treatment of Pediatric Non-Hodgkin Lymphomas: Present and FutureFollicular lymphoma: 2011 update on diagnosis and managementFollicular lymphoma: 2014 update on diagnosis and managementDenileukin diftitox: a biotherapeutic paradigm shift in the treatment of lymphoid-derived disordersInorganic chemistry in nuclear imaging and radiotherapy: current and future directions.Therapeutic efficacy of c-kit-targeted radioimmunotherapy using 90Y-labeled anti-c-kit antibodies in a mouse model of small cell lung cancer.Radioimmunotherapy for B-cell lymphoma: Y90 ibritumomab tiuxetan and I(131) tositumomab.Evaluation of Efficacy of Radioimmunotherapy with 90Y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models.Iodine-131 tositumomab (Bexxar): radioimmunoconjugate therapy for indolent and transformed B-cell non-Hodgkin's lymphoma.Gallium nitrate for the treatment of non-Hodgkin's lymphoma.A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy--availability of suitable radionuclides.Yttrium-90 ibritumomab tiuxetan plus busulfan, cyclophosphamide, and etoposide (BuCyE) versus BuCyE alone as a conditioning regimen for non-Hodgkin lymphoma.A review of tositumomab and I(131) tositumomab radioimmunotherapy for the treatment of follicular lymphoma.Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies.Yttrium 90 ibritumomab tiuxetan in lymphoma.Epratuzumab in the therapy of oncological and immunological diseases.Primary gastric lymphoma pathogenesis and treatment: what has changed over the past 10 years?Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies.⁹⁰Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma.Radioimmunotherapy and stem-cell transplantation in the treatment of aggressive B-cell lymphoma.A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations.EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinomaI-Tositumomab in lymphoma.EphA2 targeted chemotherapy using an antibody drug conjugate in endometrial carcinoma.Radioimmunotherapy for the treatment of non-Hodgkin lymphoma: current status and future applications.I-131 tositumomab.Current status of targeted therapies for mantle cell lymphoma.Radioimmunoconjugates for treating cancer: recent advances and current opportunities.Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma.Efficacy of 90Y ibritumomab-tiuxetan treatment in a case of resistant gastric MALT non-Hodgkin's lymphoma.Follicular lymphoma: 2015 update on diagnosis and management.The conjugate Rituximab/saporin-S6 completely inhibits clonogenic growth of CD20-expressing cells and produces a synergistic toxic effect with Fludarabine.Physicochemical Evaluation of Lyophilized Formulation of p-SCN-Bn-DOTA- and p-SCN-Bn-DTPA-rituximab for NHL Radio Immunotherapy.Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology.Allogeneic hematopoietic cell transplantation following conditioning with 90Y-ibritumomab-tiuxetan.Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma.Follicular lymphoma: 2018 update on diagnosis and management.PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphoma.Rituximab-ESHAP as a mobilization regimen for relapsed or refractory B-cell lymphomas: a comparison with ESHAP.
P2860
Q22252956-4502A40C-1B54-474F-9240-1AE416E85E93Q26746934-A22B58FA-73E0-49BC-A493-99FDCD516A0BQ26851450-854683D6-756B-41AA-B629-93F7FC2EB4CFQ27021850-9E51DFAE-AA4F-46C4-957C-C84C93B658E3Q28280510-44C4665A-1604-48DD-86C8-E34406D5F55CQ34460892-846D6758-E1D3-4CE1-9256-CE55EB04EAAEQ34630373-4B371521-1C95-4859-99B6-D5D21BF17B2BQ34631795-B486D5C9-266E-476B-8E55-4110FD385E93Q35499776-C5279934-7AB6-4E5C-9B51-6A49F1D3EC14Q35641192-D89B4725-A4B8-448C-AC76-F3145BCE7B5CQ35779262-E87A3D40-CDB9-45A0-9B78-114F6B9EA5BCQ35831439-2852B6DF-C344-4EA7-A96E-6C9572F33028Q36074023-D1F912EB-B5DA-41D2-A59B-B991A274490BQ36150468-A9485E26-8B50-4E92-B440-6ACEDA1DB2E1Q36426877-7A489101-C531-4B59-8621-0899A5B592EFQ36535485-D58A66CC-FB31-4587-9DB7-53578FAB4D19Q36636619-C23BD6BF-5361-4DBE-8272-B2E43373D7FAQ36677699-89A3BCA1-1CBF-4565-8CA4-37110FF06B75Q36832137-517C0E7A-A83A-40B1-9B0F-BA2045A7F62EQ36905562-D9361353-27DC-4E16-9344-7E3310DA2565Q36950052-9F55264B-5D3D-47BB-943C-1EC25E3AABBDQ37201878-69D2B26D-E902-4631-B2A3-0160DB8799AFQ37329160-C41E3692-8006-430C-AC08-A75100565071Q37401659-DCC17708-4959-4146-9BEA-03610E5F2143Q37638935-4E7AE1AD-1F66-4DD4-A121-7A547B7967C8Q37752447-7EBAF4C2-CB18-4BC7-8ABD-96584BFAED69Q37768797-FC3D49F6-8310-4380-B448-2C06744FAD1CQ37956405-F9A3A435-ADFF-483D-9F4C-77A33E056FA6Q38691472-046002C9-7A98-4EA4-B57D-9A7AC33421FEQ38716531-F5D354EA-BEE0-46D6-AA5A-7B7FBEEAB0D1Q39690225-59060972-E802-46BF-8CBB-6FC186345037Q40122693-7B963185-0D55-415D-9DD8-EEACEEFECB50Q40563800-1C09DCCF-6207-463E-A8D3-71158BC215D0Q42355121-AB6C19D0-DC58-4546-88F7-EAF07B6E82DCQ46602218-CBCF44D1-C526-44E1-B8DB-80667BAC6F61Q46830766-A00001C4-C833-4982-A296-5026202986B1Q46890986-4C5896A3-749B-470F-85B2-F076B359FE09Q47219215-DC9CB8BB-8A43-4193-8FC2-CCED0C84ADE2Q53083933-A67CC447-9DBE-4B95-9C39-5504999373DBQ53566249-DD74B8E7-9C8F-4FA7-8C45-EAE1EC43AC4B
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Radioimmunotherapy of non-Hodgkin lymphomas.
@ast
Radioimmunotherapy of non-Hodgkin lymphomas.
@en
Radioimmunotherapy of non-Hodgkin lymphomas.
@nl
type
label
Radioimmunotherapy of non-Hodgkin lymphomas.
@ast
Radioimmunotherapy of non-Hodgkin lymphomas.
@en
Radioimmunotherapy of non-Hodgkin lymphomas.
@nl
prefLabel
Radioimmunotherapy of non-Hodgkin lymphomas.
@ast
Radioimmunotherapy of non-Hodgkin lymphomas.
@en
Radioimmunotherapy of non-Hodgkin lymphomas.
@nl
P1433
P1476
Radioimmunotherapy of non-Hodgkin lymphomas.
@en
P2093
Bruce D Cheson
P304
P356
10.1182/BLOOD-2002-06-1793
P407
P577
2002-09-19T00:00:00Z